Abstract
In search of new inhibitors of the Ser/Thr protein kinase PknB from Mycobacterium tuberculosis we carried out a structure-based virtual screening study to identify ATP-competitive inhibitors of this enzyme. These studies point out that N-phenylmethylindole-2-carboxamide is a promising scaffold for the development of new PknB inhibitors. We synthesized a small set of analogue compounds to assess the pharmacophore structural requirements and to optimize the inhibitory activity against PknB. This strategy led to the identification of compound 3, endowed with an IC50 of 20 μM, which provides a novel scaffold for further improvement of PknB inhibitors.
Keywords: Ser, Thr protein kinase PknB, mycobacterium tuberculosis, virtual screening, indole.
Letters in Drug Design & Discovery
Title:Structure-based Virtual Screening to Get New Scaffold Inhibitors of the Ser/Thr Protein Kinase PknB from Mycobacterium tuberculosis
Volume: 13 Issue: 10
Author(s): Antonio Coluccia, Giuseppe La Regina, Nathalie Barilone, María-Natalia Lisa, Andrea Brancale, Gwenaëlle André-Leroux, Pedro M. Alzari and Romano Silvestri
Affiliation:
Keywords: Ser, Thr protein kinase PknB, mycobacterium tuberculosis, virtual screening, indole.
Abstract: In search of new inhibitors of the Ser/Thr protein kinase PknB from Mycobacterium tuberculosis we carried out a structure-based virtual screening study to identify ATP-competitive inhibitors of this enzyme. These studies point out that N-phenylmethylindole-2-carboxamide is a promising scaffold for the development of new PknB inhibitors. We synthesized a small set of analogue compounds to assess the pharmacophore structural requirements and to optimize the inhibitory activity against PknB. This strategy led to the identification of compound 3, endowed with an IC50 of 20 μM, which provides a novel scaffold for further improvement of PknB inhibitors.
Export Options
About this article
Cite this article as:
Coluccia Antonio, Regina La Giuseppe, Barilone Nathalie, Lisa María-Natalia, Brancale Andrea, André-Leroux Gwenaëlle, Alzari M. Pedro and Silvestri Romano, Structure-based Virtual Screening to Get New Scaffold Inhibitors of the Ser/Thr Protein Kinase PknB from Mycobacterium tuberculosis, Letters in Drug Design & Discovery 2016; 13 (10) . https://dx.doi.org/10.2174/1570180813666160801162204
DOI https://dx.doi.org/10.2174/1570180813666160801162204 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Update on the Development of TB Vaccines
Current Pharmaceutical Biotechnology Recent Development and Application of Virtual Screening in Drug Discovery: An Overview
Current Pharmaceutical Design Update of QSAR & Docking & Alignment Studies of the DNA Polymerase Inhibitors
Current Bioinformatics Ferroquine: A New Weapon in the Fight Against Malaria
Current Medicinal Chemistry - Anti-Infective Agents Virtual Screening on Natural Products for Discovering Active Compounds and Target Information
Current Medicinal Chemistry Editorial [Hot Topic: Tuberculosis; Opportunities for Treatment Optimization (Executive Guest Editor: Jan-Willem C. Alffenaar)]
Current Pharmaceutical Design Screening Strategies to Identify New Antibiotics
Current Drug Targets Structural Bioinformatics in Broad-Spectrum Racemases: A New Path in Antimicrobial Research
Current Organic Chemistry Molecular Mechanisms in Rheumatic Diseases: Rationale for Novel Drug Development – Introduction
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Mitogen-Induced Interferon Gamma Production in Human Whole Blood: The Effect of Heat and Cations
Current Pharmaceutical Biotechnology Meet Our Editorial Board Member
Drug Delivery Letters The Risk of Progressive Multifocal Leukoencephalopathy Under Biological Agents Used in the Treatment of Chronic Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Metal-N-Heterocyclic Carbene Complexes as Anti-Tumor Agents
Current Medicinal Chemistry Pediatric Immune Dysfunction and Health Risks Following Early-Life Immune Insult
Current Pediatric Reviews Fluoroquinolones as Chemotherapeutics Against Mycobacterial Infections
Current Pharmaceutical Design From Small to Powerful: The Fragments Universe and its “Chem-Appeal”
Current Medicinal Chemistry HIV-Specific T Cells: Strategies for Fighting a Moving Target
Current HIV Research Imidazole and 1,2,4-Triazole-based Derivatives Gifted with Antitubercular Activity: Cytotoxicity and Computational Assessment
Current Topics in Medicinal Chemistry Electronic Noses in Medical Diagnostics
Current Medicinal Chemistry 4-Aryl-1,4-Dihydropyridines as Potential Enoyl-Acyl Carrier Protein Reductase Inhibitors: Antitubercular Activity and Molecular Docking Study
Current Topics in Medicinal Chemistry